{"nct_id":"NCT01641107","title":"Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2014-12-04","start_date_type":"ACTUAL","primary_completion_date":"2020-04-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}